Concepedia

A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer

Margie Gerena-Lewis, Jeffrey Crawford, Philip Bonomi, Ann Marie Maddox, John D. Hainsworth, David McCune, Rakesh Shukla, Haoyue Zeigler, Paul E. Hurtubise, Tracy R. Chowdhury,

American Journal of Clinical Oncology · 2009 · 30 citations · 16 references

DOI

Abstract

Denileukin diftitox at current dose schedule has limited activity in patients with previously treated NSCLC, manifested by disease control without impact on survival.

References

16

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text

Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens

Frank V. Fossella, Russell F. DeVore, Ronald N. Kerr et al. · Journal of Clinical Oncology · 2000 · 1.4K citations

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

E.Y. Woo, Christina Chu, Theresa J. Goletz et al. · PubMed · 2001 · 1.1K citations

, , +15

Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation

Edward Y. Woo, Heidi Yeh, Christina Chu et al. · The Journal of Immunology · 2002 · 696 citations · Full text

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

Frank V. Fossella, J S Lee, Dongjun Shin et al. · Journal of Clinical Oncology · 1995 · 257 citations